Diabetes Board decisions

The Board denied the Veteran's claims for higher ratings for his service-connected diabetes mellitus, type II and related peripheral neuropathy conditions. The Veteran's vision problems were found not to be secondary to his service-connected diabetes mellitus, type II.

The Veteran's petition to reopen claims for service connection for hypertension, myocardial infarction, stroke, diabetes mellitus, and chronic kidney disease secondary to hypertension is granted. The claim for service connection for COPD is remanded.

The Board has remanded the claims for bilateral hearing loss, tinnitus, hypertension (secondary to diabetes mellitus), diabetes mellitus, a bilateral eye disorder, missing toes of the right foot, and a quarter of the left leg amputated. The Veteran is required to provide updated VA treatment records and any private treatment records from Oklahoma City. Additional development may be necessary.

The Veteran's claim for service connection for diabetes mellitus, type II and an initial rating in excess of 30 percent for PTSD prior to March 23, 2016 has been denied due to lack of evidence supporting a direct relationship between the conditions and his military service.

The Veteran's cause of death is due to underlying causes of coronary artery disease and diabetes mellitus, type 2. The Board finds that the Veteran was exposed to herbicide agents during service in Vietnam and grants service connection for his cause of death.

The Veteran's diabetes mellitus type 2 is granted as presumptively related to herbicide exposure during service. Headaches and hypertension are denied.

The Board has remanded the Veteran's claims of service connection for diabetes mellitus type II and an acquired psychiatric condition due to a lack of examination or opinion on these issues.

The Veteran's petition to reopen his claim of entitlement to service connection for diabetes was granted. The appeal is remanded for further action on the PTSD and TDIU claims.

The Veteran's claim of service connection for diabetes mellitus has been reopened, but the issue remains denied. The effective dates for other claims have not been established.

The Board has remanded the cases for issuance of an SOC addressing the issues of higher ratings for diabetic neuropathy of the bilateral lower extremities. The TDIU issue is also being remanded.

The Board has remanded the claims for accrued benefits and substitution of claimant due to a request from the appellant. The issues will be reconsidered after determining if the appellant is qualified as a substitute.

The Veteran's claims for service connection for peripheral neuropathy, diabetes mellitus type II (DM II), and prostate cancer due to herbicide agent exposure have been granted. The claim for secondary service connection for peripheral neuropathy of each extremity due to DM II has also been granted.,Service connection is established for the Veteran’s peripheral neuropathy, diabetes mellitus type II (DM II), and prostate cancer based on presumed exposure to herbicide agents during active duty.

The Board has remanded the claims for type 2 diabetes mellitus, ischemic heart disease, and bilateral hearing loss due to potential herbicide exposure. Additional development is needed to corroborate the Veteran's assertions of exposure and determine the etiology of his current conditions.

The Board has decided to remand the case due to a need for further processing regarding substitution of the Veteran's claim for service connection for erectile dysfunction as secondary to diabetes mellitus.

The Board has remanded the Veteran's claims for service connection for coronary artery disease and diabetes mellitus, type 2 due to incomplete development regarding his claimed Vietnam-era service.

The Veteran's claim for service connection for diabetes mellitus, type 2 and ischemic heart disease as due to exposure to herbicides has been remanded due to the need for further verification of exposure in Korea.

The Board has granted service connection for diabetes mellitus type II and prostate cancer, both presumed to have been incurred in service due to exposure to Agent Orange.

The Board has remanded the claims of service connection for peripheral neuropathy of the bilateral upper and lower extremities, as these are inextricably intertwined with the claim of service connection for diabetes mellitus, type II. The RO should adjudicate the supplemental claim of diabetes mellitus, type II before readjudicating the peripheral neuropathy claims.

The Veteran's prostate cancer and diabetes mellitus, type II are granted service connection as due to herbicide agent exposure. The Board has remanded for further examination on the remaining issues.

The Veteran's increased rating claim for diabetes mellitus type II with retinopathy and erectile dysfunction was denied. Separate compensable ratings were also not granted for diabetic retinopathy or erectile dysfunction.